Abstract:Haidong Cheng, 1, * Gaowa Sharen, 2, * Zhaoyang Wang, 1 Jing Zhou 3 1 Department of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China; 2 Department of Pathological Anatomy, College of Basic Medicine of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China; 3 Department of Pharmacology, College of Basic Medicine of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China *These authors contributed equally to this work Correspondence: Zhaoyang Wang Department of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China Email wzydoc@126.com Jing Zhou Department of Pharmacology, College of Basic Medicine of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China Email 591716788@qq.com Background: Chemoresistance contributes to treatment failure of gastric cancer (GC) patients but the molecular mechanism of chemoresistance in GC is still unclear. Long-chain noncoding RNA (lncRNA) urothelial cancer associated 1 ( UCA1 ) is associated with resistance to chemotherapy drugs. Methods: We detected the expression of UCA1 in 53 pairs of GC tumor tissue and adjacent normal tissue, human normal gastric mucosa cells (GES-1) and human GC cells (HGC-27, SNU-5, AGS, SGC-7901, and NCI-N87) using RT-qPCR. Small RNA interference technology was used to knock down the expression of UCA1 in gastric cancer cells. CCK8 solution was used to detect cell viability. Flow cytometry was used to detect apoptosis, and Western blotting was used to detect protein expression. Results: UCA1 was highly expressed in GC tissues and cells, and knockdown of UCA1 increased chemosensitivity to cisplatin by inducing cell apoptosis. Furthermore, UCA1 promoted CYP1B1 expression by binding to miR-513a-3p in human GC cells in vitro, and UCA1 / CYP1B1 expression was negatively related to miR-513a-3p expression, while UCA1 expression was positively related to CYP1B1 expression in human GC tissues. Moreover, overexpression of miR-513a-3p or knockdown of CYP1B1 increased chemosensitivity to cisplatin, and knockdown of miR-513a-3p or overexpression of CYP1B1 decreased chemosensitivity to cisplatin by inducing cell apoptosis in human GC cells. Importantly, overexpression of CYP1B1 reduced chemosensitivity to cisplatin which increased by knockdown of UCA1 , and knockdown of CYP1B1 increased chemosensitivity to cisplatin which decreased by knockdown of miR-513a-3p in human GC cells. Conclusion: The lncRNA UCA1 / miR-513a-3p / CYP1B1 axis regulates cisplatin resistance in human GC cells; hence, it is a potential target for treating chemoresistance in GC. Keywords: gastric cancer, urothelial cancer associated 1, chemoresistance

Downregulation of long non‑coding RNA UCA1 enhances the radiosensitivity and inhibits migration via suppression of epithelial‑mesenchymal transition in colorectal cancer cells.

Knockdown of Long Noncoding RNA Urothelial Carcinoma Associated 1 Inhibits Colorectal Cancer Cell Proliferation and Promotes Apoptosis Via Modulating Autophagy

Lncrna Uca1 In Anti-Cancer Drug Resistance

LncRNA-UCA1 Enhances Cell Proliferation and 5-Fluorouracil Resistance in Colorectal Cancer by Inhibiting Mir-204-5p.

Down-regulation of lncRNA UCA1 enhances radiosensitivity in prostate cancer by suppressing EIF4G1 expression via sponging miR-331-3p

UCA1, a Long Non-Coding RNA Up-Regulated in Colorectal Cancer Influences Cell Proliferation, Apoptosis and Cell Cycle Distribution

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

Increased Urothelial Cancer Associated 1 Is Associated With Tumor Proliferation And Metastasis And Predicts Poor Prognosis In Colorectal Cancer

Long Non-Coding Rna Uca1 Induces Non-T790m Acquired Resistance to Egfr-Tkis by Activating the Akt/Mtor Pathway in Egfr-Mutant Non-Small Cell Lung Cancer

lncRNA UCA1 Increases Proliferation and Multidrug Resistance of Retinoblastoma Cells Through Downregulating miR-513a-5p

Long Non‑coding RNA Urothelial Cancer Associated1 Regulates Radioresistance Via the Hexokinase2/glycolytic Pathway in Cervical Cancer

Overexpression of Long Non-Coding RNA Urothelial Carcinoma Associated 1 (LncRNA UCA1) Affects Paclitaxel (Taxol) Resistance in Colorectal Cancer Cells through the Promotion of Glycolysis

Long Non-Coding RNA UCA1 Promotes Lung Cancer Cell Proliferation and Migration Via Microrna-193A/hmgb1 Axis.

Downregulation of Mir-1 in Colorectal Cancer Promotes Radioresistance and Aggressive Phenotypes.

Long Non‐coding RNA UCA1 Increases Chemoresistance of Bladder Cancer Cells by Regulating Wnt Signaling

LncRNA UCA1 Enhances Cisplatin Resistance by Regulating CYP1B1-mediated Apoptosis via miR-513a-3p in Human Gastric Cancer

Expression of Long Noncoding Rna Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical Cancer

Lncrna UCA1 Inhibits Esophageal Squamous-Cell Carcinoma Growth by Regulating the Wnt Signaling Pathway

LncRNA UCA1 mediates Cetuximab resistance in Colorectal Cancer via the MiR-495 and HGF/c-MET Pathways

Long Non-Coding RNA UCA1 Promotes Cisplatin/gemcitabine Resistance Through CREB Modulating Mir-196A-5p in Bladder Cancer Cells.

Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis.